81.35000 USD
0.35
0.43%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
80.51000
83.33500
Previous close
81.70000
Open
82.33000
Access this stock data via API
Subscribe
Tarsus Pharmaceuticals Inc.
81.35
0.35
0.43%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 183.0M 17.4M 25.8M 57.0M
Cost of revenue 12.8M 1.6M 955K 2.1M
Gross profit 170.1M 15.9M 24.9M 55.0M
Operating expense
Research & development 53.4M 50.3M 42.6M 41.7M
Selling general and admin 237.3M 108.7M 44.9M 25.4M
Other operating expenses
Operating income -120.6M -143.2M -62.7M -12.2M
Non operating interest income
Income 15.0M 10.3M 3.5M 36K
Expense 7.4M 3.2M 2.1M 0
Other income expense -2.2M 274K -683K -1.7M
Pretax income -115.6M -135.9M -62.1M -13.8M
Tax provision 0 0 -4K 55K
Net income -115.6M -135.9M -62.1M -13.8M
Basic EPS -3.1 -4.6 -2.5 -0.7
Diluted EPS -3.1 -4.6 -2.5 -0.7
Basic average shares 37.6M 29.4M 24.6M 20.6M
Diluted average shares 37.6M 29.4M 24.6M 20.6M
EBITDA -104.1M -132.2M -58.9M -11.9M
Net income from continuing op. -115.6M -135.9M -62.1M -13.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 5 hours 39 minutes

22:20
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).